Zurcher Kantonalbank Zurich Cantonalbank Boosts Stake in Cooper Companies Inc (COO)

Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Cooper Companies Inc (NYSE:COO) by 4.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,071 shares of the medical device company’s stock after buying an additional 375 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Cooper Companies were worth $1,976,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Dupont Capital Management Corp grew its position in Cooper Companies by 175.3% in the fourth quarter. Dupont Capital Management Corp now owns 28,960 shares of the medical device company’s stock worth $6,310,000 after buying an additional 18,442 shares during the last quarter. Congress Asset Management Co. MA grew its position in Cooper Companies by 1.5% during the 4th quarter. Congress Asset Management Co. MA now owns 346,738 shares of the medical device company’s stock worth $75,547,000 after purchasing an additional 5,006 shares in the last quarter. LMR Partners LLP grew its position in Cooper Companies by 38.7% during the 4th quarter. LMR Partners LLP now owns 5,513 shares of the medical device company’s stock worth $1,201,000 after purchasing an additional 1,538 shares in the last quarter. Twin Capital Management Inc. purchased a new position in Cooper Companies during the 4th quarter worth approximately $2,042,000. Finally, BTIM Corp. grew its position in Cooper Companies by 4.2% during the 4th quarter. BTIM Corp. now owns 50,236 shares of the medical device company’s stock worth $10,945,000 after purchasing an additional 2,015 shares in the last quarter. 95.04% of the stock is currently owned by hedge funds and other institutional investors.

Several equities analysts have recently commented on the stock. Cleveland Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Friday, February 9th. Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, January 8th. Oppenheimer set a $250.00 price objective on shares of Cooper Companies and gave the company a “hold” rating in a research note on Friday, December 8th. Stifel Nicolaus reissued a “buy” rating and set a $265.00 target price (down previously from $275.00) on shares of Cooper Companies in a research report on Friday, December 8th. Finally, Raymond James Financial reissued a “buy” rating and set a $265.00 target price on shares of Cooper Companies in a research report on Monday, December 4th. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $259.70.

In related news, CEO Robert S. Weiss sold 32,500 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $224.70, for a total value of $7,302,750.00. Following the completion of the transaction, the chief executive officer now owns 119,111 shares of the company’s stock, valued at $26,764,241.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Allan E. Rubenstein sold 6,450 shares of the firm’s stock in a transaction on Friday, January 12th. The shares were sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the completion of the transaction, the director now directly owns 8,628 shares of the company’s stock, valued at approximately $1,974,000.12. The disclosure for this sale can be found here. Over the last quarter, insiders sold 54,385 shares of company stock worth $12,289,463. Company insiders own 1.60% of the company’s stock.

Shares of Cooper Companies Inc (NYSE COO) traded down $0.06 during mid-day trading on Monday, hitting $232.47. 418,600 shares of the stock were exchanged, compared to its average volume of 486,373. Cooper Companies Inc has a 12 month low of $190.18 and a 12 month high of $256.39. The firm has a market capitalization of $11,396.00, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 1.87 and a beta of 0.57. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26.

Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The business had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. During the same period in the prior year, the business posted $2.28 earnings per share. Cooper Companies’s revenue was up 8.3% compared to the same quarter last year. equities research analysts anticipate that Cooper Companies Inc will post 11.55 earnings per share for the current year.

The company also recently announced a semiannual dividend, which was paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd were issued a $0.03 dividend. The ex-dividend date was Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.80%.

TRADEMARK VIOLATION WARNING: This piece was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/19/cooper-companies-inc-coo-stake-boosted-by-zurcher-kantonalbank-zurich-cantonalbank.html.

Cooper Companies Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply